John W Newcomer MD

Psychiatry•Miami, FL

President and Chief Executive Officer Thriving Mind South Florida

Join to View Full Profile

7205 Corporate Center Drivesuite 200Miami, FL 33126

Summary

Dr, Newcomer is President and CEO of Thriving Mind South Florida, with funding of >$140 million/year. He is also Adjunct Professor of Psychiatry at Washington University School of Medicine. PI on NIH and SAMHSA grants for >30 years, he Chaired Missouri Medicaid Drug Utilization Review Board for 13 years, and was named to Thomson Reuters List of Highly Cited Researchers.

Home - Thriving Mind

Thriving Mind | South Florida (Contracting as South Florida Behavioral Health Network, Inc.) promotes access to effective, accountable and compassionate care fo

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1986 - 1989
Detroit Medical Center/Wayne State University (Sinai Grace)Internship, Internal Medicine, 1985 - 1986
Wayne State University School of MedicineClass of 1985, MD, Alpha Omega Alpha
Brown UniversityAB, Philosophy of Science, Phi Beta Kappa, 1977 - 1981

Certifications & Licensure

FL State Medical License 2011 - 2026
CA State Medical License 1986 - 2020
MO State Medical License 1990 - 2019
MI State Medical License Active through 1986
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Thomson Reuters List of Highly Cited Researchers 2014

Clinical Trials

Glucose Regulation During Risperidone and Olanzapine Treatment
Unknown status
Not Applicable
Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole Start of enrollment: 2005 Feb 01
Completed
Phase 4
Metabolic Effects of Antipsychotics in Children Start of enrollment: 2006 Apr 01
Completed
Phase 4
Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids Start of enrollment: 2003 Feb 01
Completed
Phase 4
Pfizer/IVGTT/Ziprasidone/Olanzapine Start of enrollment: 2000 Nov 01
Completed
Not Applicable
Janssen - Glucose Regulation/Risp/Olanz Start of enrollment: 2000 Jul 01
Completed
Not Applicable
Glucose and Lipid Metabolism on Antipsychotic Medication Start of enrollment: 2001 Sep 01
Completed
Not Applicable
Effects of Antipsychotic Medications on Energy Intake and Expenditure Start of enrollment: 2006 Apr 01
Completed
Metabolic Effects of Antipsychotic Substitution in Children Start of enrollment: 2009 Nov 01
Withdrawn
Phase 2, Phase 3
Treatment Resistant Depression (Pilot) Start of enrollment: 2012 Apr 01
Completed
Not Applicable
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol Start of enrollment: 2016 Jun 08
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Revisiting diabetes risk of olanzapine versus aripiprazole in serious mental illness care.
Denis Agniel, Sharon-Lise T Normand, John W Newcomer, Katya Zelevinsky, Jason Poulos
Bjpsych Open. 2024-08-08
1 citations
Lurasidone and risk of metabolic syndrome: results from short and long-term studies in patients with bipolar depression.
Michael Tocco, John W Newcomer, Yongcai Mao, Andrei Pikalov
CNS Spectrums. 2023-12-01
2 citations
Antipsychotics and the risk of diabetes and death among adults with serious mental illnesses.
Jason Poulos, Sharon-Lise T Normand, Katya Zelevinsky, John W Newcomer, Denis Agniel
Psychological Medicine. 2023-12-01

Journal Articles

Diabetes and Prediabetes Prevalence by Race and Ethnicity Among People with Severe Mental Illness
Christina V Mangurian, Dean Schillinger, John W Newcomer, Diabetes Care
Diabetes and Prediabetes Prevalence by Race and Ethnicity Among People with Severe Mental Illness
Christina V. Mangurian, John W. Newcomer, Diabetes Care

Press Mentions

She Went from a ‘Dark Period’ in High School to Preaching About Suicide PreventionMarch 10th, 2023
Round-the-Clock Mental-Health Services Available for Those Touched by Surfside Collapse | OpinionJuly 20th, 2021
The Overlooked Opioid Crisis in Latinx CommunitiesMarch 2nd, 2020
Join now to see all

Grant Support

Cooperative Agreement for Expansion and Sustainability of the Comprehensive Community Mental Health Services for Children with Serious Emotional DisturbancesSAMHSA2018–2022
Adaptation of an Evidence-based Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Early Serious Mental Illness: iOTA-eSMINIMH2019–2021
Metabolic Effects Of Antipsychotics In ChildrenNational Institute Of Mental Health2006–2010
Metabolic Effects Of Antipsychotics In ChildrenNational Center For Research Resources2006–2007
Aripiprazole IvgttNational Center For Research Resources2006–2007
Glucose And Lipid Metabolism On Antipsychotic MedicationNational Center For Research Resources2005–2007
Glucocorticoid Regulation Of Memory Performance In Aging HumansNational Center For Research Resources2005–2007
Kids KetamineNational Center For Research Resources2004–2007
A Pilot Study Of Metabolic Effect Of Antipsychotics In ChildrenNational Center For Research Resources2005–2006
Glucose Regulation During Risperidone And Olanzapine TreatmentNational Center For Research Resources2005
Antipsychotic MedicationNational Institute Of Mental Health2001–2005
Glucose Regulation During Risperidone And Olanzapine Treatment.National Center For Research Resources2004
Glucose And Lipid Metabolism On Antipsychotic Medication.National Center For Research Resources2004
Glucocorticoid Regulation Of Memory Performance In Aging Humans.National Center For Research Resources2004
Glucocorticoid Regulation Of Memory In Aging HumansNational Institute Of Mental Health2000–2003
Glucose Enhancement Of Memory/Attention In SchizophreniaNational Center For Research Resources2000–2002
Glucocorticoid Regulation Of Memory Performance In AgingNational Center For Research Resources2000–2002
Neuroendocrinology Of Memory And Aging In SchizophreniaNational Center For Research Resources1999–2002
Preventing Nrh Induced Symptoms In HumansNational Center For Research Resources1998–2002
Neurochemical Control Of Memory In Aging SchizophrenicsNational Institute Of Mental Health1997–2001
Leptin And Weight Loss In Major Depressive DisorderNational Center For Research Resources1999
Insulin Regulation Of Memory Performance During Normal AgingNational Center For Research Resources1997–1999
Cognitive And Behavioral Effects Of Subanesthetic Doses Of KetamineNational Center For Research Resources1996–1999
Accelerated Hippocampal Aging In SchizophreniaNational Center For Research Resources1996–1999
Neuroendocrinology Of Memory And Aging In SchizophreniaNational Institute Of Mental Health1996–1998
Effects Of Cortisol On Cognitive Performance In Aging HumansNational Center For Research Resources1996–1997
Accelerated Hippocampal Aging In Schizophrenia PatientsNational Institute Of Mental Health1992–1996